Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes
角膜淋巴管生成中 VEGF 受体二聚化和信号传导的抑制
基本信息
- 批准号:8177528
- 负责人:
- 金额:$ 23.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlkaliesBindingBiosensorBlindnessBurn injuryCell ProliferationCellsCorneaCorneal DiseasesCorneal InjuryDataDevelopmentDimerizationDiseaseDoseDown-RegulationEndostatinsEquilibriumEventFibroblast Growth Factor 2Fluorescence Resonance Energy TransferGoalsHeterodimerizationHomodimerizationHumanIn VitroInfectionInvestigationLungLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphatic SystemLymphatic vesselMeasuresMethodsMolecularPathologicPathologyPeptidesPhosphorylationPhosphotransferasesPhysiologicalPlayProcessProductionRegulationRoleSignal TransductionTestingVascular Endothelial Growth Factor CVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3Vascular Endothelial Growth FactorsWound Infectionangiogenesisbaseconjunctivacorneal epitheliumdesignin vivoinhibitor/antagonistnovelnovel therapeutic interventionocular surfacereceptorresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Corneal lymphangiogenesis follows severe corneal injuries and infections and is one of the major causes of blindness. Under normal physiological conditions, the cornea is alymphatic and surrounded by lymphatic vessels residing in the conjunctiva while corneal lymphangiogenic privilege is maintained. However, wounding and infection induce corneal lymphangiogenesis. The extrinsic factors that regulate corneal lymphangiogenic privilege include: 1) the presence of angiogenic and lymphangiogenic factors (VEGF-A, -C and -D); 2) expression of sVEGFR-2 in the cornea; 3) expression of VEGFR-3 in corneal epithelium and other anti-lymphangiogenic factors in the cornea. The status of corneal lymphangiogenesis is controlled by the balance of pro- and anti- lymphatic factors. The current hypothesis of corneal lymphangiogenic privilege is governed by extrinsic factors unique to the cornea. Besides the well-documented extrinsic factors involved in regulating corneal lymphangiogenic privilege, changes in the VEGFR-2 may regulate VEGFR3-activation in lymphatic cells also regulate corneal lymphangiogenesis. Our preliminary data demonstrated corneal lymphangiogenesis in diseased human corneas, which correlated with enhanced VEGFR-3 expression in alkali-burn-wounded corneas. In addition, endostatin-containing fragments bind to VEGFR-3 in vitro and have better inhibition of bFGF-induced corneal lymphangiogenesis than angiogenesis. VEGF- C-induced VEGFR-3 dimerization and low dose VEGF-C has better potency in promoting lymphatic cell proliferation. Our long-term objective is to identify the mechanisms that regulate corneal lymphangiogenesis. The proposed experiments are designed to determine the role of VEGF-C-induced VEGFR-3 homodimerization regulated by VEGF-2/-3 heterodimerization and to investigate selective inhibitors for the inhibition of VEGFR-3 homodimerization during corneal lymphangiogenesis.
PUBLIC HEALTH RELEVANCE: Lymphangiogenesis is the process of increased production of lymphatic vessels and can be both physiological and pathological. We hypothesize that VEGFR-2 interferes with VEGFR-3 dimerization may play a role in the regulation of corneal lymphangiogenesis. Understanding the molecular mechanisms of corneal lymphangiogenesis will provide novel therapeutic interventions in the treatment of lymphangiogenesis-related disorders.
描述(由申请人提供):角膜淋巴管生成是严重角膜损伤和感染后发生的,是导致失明的主要原因之一。在正常的生理条件下,角膜是淋巴性的,被居住在结膜的淋巴管包围,而角膜的淋巴管生成特权保持不变。然而,损伤和感染可诱导角膜淋巴管生成。调节角膜淋巴管生成特权的外在因素包括:1)血管生成因子和淋巴管生成因子(VEGF-A、-C和-D)的存在;2) sVEGFR-2在角膜中的表达;3) vegf -3在角膜上皮中的表达及角膜内其他抗淋巴管生成因子的表达。角膜淋巴管生成的状态是由促淋巴因子和抗淋巴因子的平衡控制的。目前角膜淋巴管生成特权的假设是由角膜特有的外在因素决定的。除了有充分证据表明参与调节角膜淋巴管生成特权的外在因素外,VEGFR-2的变化可能调节淋巴细胞中vegfr3的激活,也调节角膜淋巴管生成。我们的初步数据表明,患病的人角膜中存在角膜淋巴管生成,这与碱烧伤损伤角膜中VEGFR-3表达的增强有关。此外,含有内皮抑素的片段在体外与VEGFR-3结合,对bfgf诱导的角膜淋巴管生成的抑制作用优于血管生成。VEGF- c诱导的VEGFR-3二聚化和低剂量VEGF- c对淋巴细胞增殖有较好的促进作用。我们的长期目标是确定调节角膜淋巴管生成的机制。本实验旨在确定vegf - c诱导的由VEGF-2/ 3异源二聚化调节的VEGFR-3同二聚化的作用,并研究在角膜淋巴管生成过程中抑制VEGFR-3同二聚化的选择性抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIN-HONG CHANG其他文献
JIN-HONG CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIN-HONG CHANG', 18)}}的其他基金
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
调节 VEGF 受体预防角膜缘干细胞移植排斥
- 批准号:
10683941 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
调节 VEGF 受体预防角膜缘干细胞移植排斥
- 批准号:
10155431 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
调节 VEGF 受体预防角膜缘干细胞移植排斥
- 批准号:
10455420 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Endostatin-derived Short Peptides in Corneal Transplantation
内皮抑素衍生的短肽在角膜移植中的应用
- 批准号:
8811330 - 财政年份:2014
- 资助金额:
$ 23.86万 - 项目类别:
Endostatin-derived Short Peptides in Corneal Transplantation
内皮抑素衍生的短肽在角膜移植中的应用
- 批准号:
8627925 - 财政年份:2014
- 资助金额:
$ 23.86万 - 项目类别:
Endostatin-derived Short Peptides in Corneal Transplantation
内皮抑素衍生的短肽在角膜移植中的应用
- 批准号:
9280824 - 财政年份:2014
- 资助金额:
$ 23.86万 - 项目类别:
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis
VEGFR2 调节角膜血管生成和淋巴管生成
- 批准号:
8569510 - 财政年份:2013
- 资助金额:
$ 23.86万 - 项目类别:
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis
VEGFR2 调节角膜血管生成和淋巴管生成
- 批准号:
8702186 - 财政年份:2013
- 资助金额:
$ 23.86万 - 项目类别:
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes
角膜淋巴管生成中 VEGF 受体二聚化和信号传导的抑制
- 批准号:
8309043 - 财政年份:2011
- 资助金额:
$ 23.86万 - 项目类别:
Collagen XVIII in Corneal Neovascularization
XVIII 胶原蛋白在角膜新生血管中的作用
- 批准号:
7105535 - 财政年份:2003
- 资助金额:
$ 23.86万 - 项目类别:
相似海外基金
Understanding the Volatile Evolution of Arc Magmas: Alkalies and Mixed (H2O + CO2) Volatile Solubility in Basalts and Basaltic Andesites
了解弧岩浆的挥发性演化:玄武岩和玄武安山岩中的碱金属和混合 (H2O CO2) 挥发性溶解度
- 批准号:
0838563 - 财政年份:2009
- 资助金额:
$ 23.86万 - 项目类别:
Standard Grant
Clinker's coating:role of alkalies and refractories texture
熟料的涂层:碱和耐火材料质地的作用
- 批准号:
200906-1996 - 财政年份:1999
- 资助金额:
$ 23.86万 - 项目类别:
Collaborative Research and Development Grants
Clinkers coating:role of alkalies and refractories texture
熟料涂层:碱和耐火材料质地的作用
- 批准号:
200906-1996 - 财政年份:1998
- 资助金额:
$ 23.86万 - 项目类别:
Collaborative Research and Development Grants
Clinker's coating:role of alkalies and refractories texture
熟料的涂层:碱和耐火材料质地的作用
- 批准号:
200906-1996 - 财政年份:1997
- 资助金额:
$ 23.86万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




